Your Article Summary
See Latest ArticlesBone Cancer Pain
Pain: Clinical Updates (IASP’s clinical newsletter), 06/25/09
Jimenez-Andrade JM et al. - Over the last decade, progress has been made in laying the foundation for a mechanism-based understanding of the factors that drive bone cancer pain. Interestingly, several therapies that attenuate bone cancer pain may also reduce tumor growth and tumor-induced bone remodeling. Thus, bisphosphonates are commonly used to treat bone cancer pain, and other therapies including denosumab (anti-RANKL; Amgen), tanezumab (anti-NGF; Pfizer), and pregabalin (Pfizer) are in mid- to latestage clinical trials. Currently, we are beginning to understand the mechanisms that drive bone cancer. If this progress can be sustained and expanded, these advances have the potential to enlarge the repertoire of therapies available to treat bone cancer pain and significantly improve the quality of life, functional status, and survival of patients with bone cancer.
Related Articles
Feasibility study of Transcutaneous Electrical Nerve Stimulation (TENS) for Cancer Bone Pain
The Journal of Pain, 10/26/09
Relevance Score: 83%
The role of N-methyl-d-aspartate receptor subunit NR2B in spinal cord in cancer pain
European Journal of Pain, 10/09/09
Relevance Score: 83%
A phase 2 trial exploring the effects of high-dose (10,000 IU/day) Vitamin D3 in breast cancer patients with bone metastases
Cancer, 11/18/09
Relevance Score: 81%
Preclinical and Early Clinical Investigations Related to Monoaminergic Pain Modulation
Neurotherapeutics, 10/05/09
Relevance Score: 81%
Unusual location of a urinary bladder cancer metastasis
Radiology Case Reports, 10/15/09
Relevance Score: 79%
Today in Bone/Cartilage...keeping you current
Receive free subspecialty "5-minute updates" via email
Prostate cancer cells modulate osteoblast mineralisation and osteoclast differentiation through Id-1
British Journal of Cancer, 12/18/09
Epidermal growth factor signalling and bone metastasis
British Journal of Cancer, 12/18/09
Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis
Oncogene, 12/17/09
Today in Pain Management/Palliative Care...keeping you current
Receive free subspecialty "5-minute updates" via email
Provision of Spiritual Care to Patients With Advanced Cancer: Associations With Medical Care and Quality of Life Near Death
Journal of Clinical Oncology, 12/18/09
Sublingual administration of fentanyl to cancer patients is an effective treatment for breakthrough pain: Results from a randomized phase II study
Palliative Medicine, 12/18/09
Pain in patients with lung cancer: Pathophysiology and treatment
Lung Cancer, 12/18/09